I.Ceram S.A (ALICR) | Financial Analysis & Statements
I.Ceram S.A. | Small_cap | Healthcare
I.Ceram S.A. | Small_cap | Healthcare
Financial Overview
Latest Annual: 2023Income Metrics
Revenue
991.6K
Gross Profit
-588.2K
-59.32%
Operating Income
-1.6M
-156.97%
Net Income
-1.1M
-111.29%
EPS (Diluted)
-€3.77
Balance Sheet Metrics
Total Assets
3.9M
Total Liabilities
3.0M
Shareholders Equity
890.0K
Debt to Equity
3.35
Cash Flow Metrics
Operating Cash Flow
-771.0K
Free Cash Flow
-858.0K
Revenue & Profitability Trend
I.Ceram S.A Income Statement From 2019 to 2023
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 991.6K | 1.4M | 1.6M | 1.5M | 1.6M |
| Cost of Goods Sold | 1.6M | 1.3M | 1.3M | 468.2K | 588.6K |
| Gross Profit | -588.2K | 131.9K | 298.8K | 1.1M | 1.0M |
| Operating Expenses | 129.4K | -59.7K | 127.7K | 1.3M | 1.8M |
| Operating Income | -1.6M | -871.3K | -938.7K | -1.7M | -2.8M |
| Pre-tax Income | -1.4M | -1.2M | -908.8K | -1.6M | -2.8M |
| Income Tax | -275.8K | -290.0K | -338.0K | -52.7K | -19.9K |
| Net Income | -1.1M | -936.5K | -570.8K | -1.5M | -2.8M |
| EPS (Diluted) | -€3.77 | -€3.21 | -€1.95 | -€0.01 | -€9.40 |
Income Statement Trend
I.Ceram S.A Balance Sheet From 2019 to 2023
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 2.6M | 3.2M | 3.3M | 3.1M | 3.3M |
| Non-Current Assets | 1.3M | 1.8M | 2.4M | 2.6M | 3.3M |
| Total Assets | 3.9M | 5.0M | 5.8M | 5.7M | 6.6M |
| Liabilities | |||||
| Current Liabilities | 1.3M | 1.1M | 923.3K | 1.5M | 1.1M |
| Non-Current Liabilities | 1.7M | 1.9M | 2.1M | 1.6M | 1.3M |
| Total Liabilities | 3.0M | 3.0M | 3.0M | 3.1M | 2.5M |
| Equity | |||||
| Total Shareholders Equity | 890.0K | 2.0M | 2.7M | 2.6M | 4.1M |
Balance Sheet Composition
I.Ceram S.A Cash Flow Statement From 2017 to 2021
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -771.0K | -1.5M | -2.8M | -2.6M | -2.2M |
| Operating Cash Flow | -771.0K | -1.1M | -1.8M | -3.4M | -2.2M |
| Investing Activities | |||||
| Capital Expenditures | 45.0K | 44.0K | 11.0K | -769.0K | -901.0K |
| Investing Cash Flow | 45.0K | 232.0K | 11.0K | -752.0K | -817.0K |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | 810.0K | 234.0K | -208.0K | 2.9M | -42.0K |
| Free Cash Flow | -858.0K | -447.0K | -1.4M | -3.4M | -2.6M |
Cash Flow Trend
I.Ceram S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
9.88
Forward P/E
-2.68
Price to Book
0.46
Price to Sales
0.19
PEG Ratio
-2.68
Profitability Ratios
Profit Margin
-170.02%
Operating Margin
-185.06%
Return on Equity
-124.00%
Return on Assets
-28.52%
Financial Health
Current Ratio
1.53
Debt to Equity
476.65
Beta
0.70
Per Share Data
EPS (TTM)
-€4.16
Book Value per Share
€0.88
Revenue per Share
€2.08
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| alicr | 155.7K | 9.88 | 0.46 | -124.00% | -170.02% | 476.65 |
| Amplitude Surgical | 295.0M | 307.50 | 3.12 | 1.15% | 1.00% | 126.32 |
| Crossject S.A | 80.5M | - | - | 478.68% | 0.00% | -7.88 |
| Visiomed Group SA | 53.2M | 57.80 | 2.10 | 3.68% | 6.58% | 32.03 |
| Bonyf N.V | 8.2M | - | 18.85 | -38.97% | 8.54% | 0.00 |
| Spineway S.A | 3.9M | 0.02 | 0.07 | -17.85% | -30.35% | 7.50 |
Financial data is updated regularly. All figures are in the company's reporting currency.